Statistics for Protalix BioTherapeutics Inc (id:185 PLX)
Valuation metrics
Market cap
128.12M
Enterprise value
84.82M
Trailing P/E (ttm)
13.00
Forward P/E
2.81
PEG ratio
2.81
Price/Sales (ttm)
3.37
Price/Book (mrq)
3.78
Enterprise Value/Revenue
2.23
Enterprise Value/EBITDA
-6.27
Overview
Shares outstanding
73.63M
Float
54.66M
Shares short
3.10M
% Held by insiders
3.00%
% Held by institutions
5.00%
Average volume (10 days)
445.20K
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
1.90
52-Week change
-3.66%
Beta
3.00
50-Day moving average
1.41
200-Day moving average
1.21
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
December 20, 2019
Ex-dividend date
Last split factor
2:1
Last split date
December 20, 2019
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-38.62%
Operating margin
-18.01%
Operational effectiveness
Return on assets
-10.27%
Return on equity
-43.48%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
42.51M
EBITDA
12.94M
Net income to common (ttm)
-14,694,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
73.60%
Balance sheet
Total cash (mrq)
45.03M
Total cash per share (mrq)
3.00
Total debt (mrq)
26.15M
Total Debt/Equity (mrq)
91.50
Current ratio (mrq)
133.50%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-2,715,000.00
Levered free cash flow (LFCF)
1.32M